EVP, Operations & Program Mana of Adaptive Biotechnologies Corp (30-Year Financial, Insider Trades) Nancy Louise Hill (insider trades) sold 19,000 shares of ADPT on 06/22/2020 at an average price of $45.22 a share. The total sale was $859,180.
Adaptive Biotechnologies Corp has a market cap of $5.96 billion; its shares were traded at around $46.96 with and P/S ratio of 20.99. GuruFocus has detected 1 severe warning sign with Adaptive Biotechnologies Corp. .
CEO Recent Trades:
- CEO and Chairman Chad M Robins sold 33,132 shares of ADPT stock on 06/22/2020 at the average price of $45.85. The price of the stock has increased by 2.42% since.
- CEO and Chairman Chad M Robins sold 69,680 shares of ADPT stock on 06/19/2020 at the average price of $44.57. The price of the stock has increased by 5.36% since.
CFO Recent Trades:
- CFO Chad M Cohen sold 30,000 shares of ADPT stock on 06/09/2020 at the average price of $39.35. The price of the stock has increased by 19.34% since.
Directors and Officers Recent Trades:
- EVP, Operations & Program Mana Nancy Louise Hill sold 19,000 shares of ADPT stock on 06/22/2020 at the average price of $45.22. The price of the stock has increased by 3.85% since.
- Chief Business Development Off Sharon Benzeno sold 417 shares of ADPT stock on 06/19/2020 at the average price of $45. The price of the stock has increased by 4.36% since.
- Chief People Officer Francis Lo sold 2,000 shares of ADPT stock on 06/18/2020 at the average price of $44.34. The price of the stock has increased by 5.91% since.
- Director Robert Hershberg sold 2,000 shares of ADPT stock on 06/15/2020 at the average price of $43. The price of the stock has increased by 9.21% since.
- Chief Medical Officer Lance Baldo sold 6,250 shares of ADPT stock on 06/09/2020 at the average price of $39.67. The price of the stock has increased by 18.38% since.
For the complete insider trading history of ADPT, click here
.
